ICD-10 Codes Most Commonly Used for Blood Lead in no particular order: R78.71 Abnormal lead level in blood Z00.12 Encounter for routine child health examination Z00.121 Encounter for routine child health examination with abnormal findings
ICD-10-CM Diagnosis Code R78.71 [convert to ICD-9-CM] Abnormal lead level in blood Increased blood lead level; lead poisoning (T56.0-) ICD-10-CM Diagnosis Code Z36.1 [convert to ICD-9-CM] Encounter for antenatal screening for raised alphafetoprotein level
Encntr screen for disorder due to exposure to contaminants; Lead screening done; Screening for high lead level; those exposed to contaminants without suspected disorders (Z57.-, Z77.-) ICD-10-CM Diagnosis Code Z13.88
Oct 01, 2021 · Lead screening done Screening for high lead level Present On Admission Z13.88 is considered exempt from POA reporting. ICD-10-CM Z13.88 is grouped within Diagnostic Related Group (s) (MS-DRG v39.0): 951 Other factors influencing health status Convert Z13.88 to ICD-9-CM Code History
Type 1 Excludes. lead poisoning ( T56.0-) ICD-10-CM Diagnosis Code Z13.0 [convert to ICD-9-CM] Encounter for screening for diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism. Encntr screen for dis of the bld/bld-form org/immun mechnsm; Screening for anemia due to vitamin or mineral deficiency ...
DOM covers CPT code 83655 (lead testing) outside of the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) or wellness benefit for all beneficiaries when billed with a QW modifier. The ICD-10 code for contact with and (suspected) exposure to lead is Z77. 011.Feb 25, 2016
AppendixInformation in the [brackets] below has been added for clarification purposes. Codes requiring a 7th character are represented by "+":CodeCode DescriptionCPT Codes covered if selection criteria are met:83655Lead [not covered for measurement of lead in bone, hair, teeth, or urine]32 more rows
ICD-10-CM Code for Encounter for general adult medical examination without abnormal findings Z00. 00.
Z13. 88 - Encounter for screening for disorder due to exposure to contaminants | ICD-10-CM.
Description: Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count.Oct 1, 2018
US Preventative Service Task Force: Screening for elevated lead levels by measuring blood lead at least once at age 12 months is recommended for: All children at increased risk of lead exposure. All children with identifiable risk factors.
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.Feb 24, 2022
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.Mar 13, 2019
Encounter for screening for other metabolic disorders The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.
Code Z13. 89, encounter for screening for other disorder, is the ICD-10 code for depression screening.Oct 1, 2016
0 - 17 years inclusiveZ00. 129 is applicable to pediatric patients aged 0 - 17 years inclusive.
ICD-10-CM Code for Contact with and (suspected) exposure to other hazardous metals Z77. 018.
The Centers for Disease Control and Prevention defines lead poisoning as a blood lead level of 10 mg/dL.
When lead-based paint peels and chips off of older walls, it can be inhaled and cause permanent damage to a young child's nervous system. Recurrent exposure to even small amounts of lead may result in lead poisoning since lead can accumulate in the body. Neurobehavioral abnormalities of mild lead poisoning may manifest as lowered IQ scores, decreased attention span, impaired hearing, speech and other developmental delays; however, most children of pre-school age with mild lead poisoning are asymptomatic. The probability of developing encephalopathy, the most serious complication of lead poisoning, increases as the exposure to lead and blood level of lead rises. Encephalopathy may be preceded by abdominal pain, headaches, vomiting, and constipation. The Centers for Disease Control and Prevention defines lead poisoning as a blood lead level of 10 mg/dL. As sustained blood levels rise above 10 to 15 mg/dL, young children under age 6 years are at progressively increasing risk not only for future neurobehavioral and cognitive problems, but also for development of recurrent symptomatic episodes of physical manifestations of lead poisoning.
Note: Routine blood lead testing for average-risk pregnant women without risk factors is not considered medically necessary. Aetna considers measurement of lead in bone, hair, teeth, or urine experimental and investigational because the effectiveness of these approaches has not been established.
Neurobehavioral abnormalities of mild lead poisoning may manifest as lowered IQ scores, decreased attention span, impaired hearing, speech and other developmental delays; however, most children of pre-school age with mild lead poisoning are asymptomatic.
The blood lead level is a good indicator of exposure that has occurred within the previous few weeks . In interpreting the results, it is important to use levels appropriate to adult toxicity, rather than children's (which sometimes are the ranges of concern reported by the testing laboratories)".
Wang and associates (2019) noted that inorganic arsenic (iAs) and Pb rank first and second on the U.S. Environmental Protection Agency (EPA)'s priority list of hazardous substances. Both are known neurotoxic metals that cause detrimental effects on brain development and lead to deficits in cognitive function and behavioral performance in children. Studies have indicated a potential link between iAs and Pb exposure and a higher risk for autism spectrum disorders (ASD). To provide further insight into whether developmental exposure to iAs or Pb is associated with ASD, these investigators carried out a systematic review and combined data into a meta-analysis to examine the available human evidence on the relationships. They reviewed relevant studies published through December 30, 2018 and identified 14 studies on iAs and 37 studies on Pb exposure and their respective associations with ASD. Among them, 8 (53.3 %) and 19 (51.3 %) studies reported a positive association for iAs and Pb, respectively, and none reported a sole inverse association. In the following meta-analysis, these researchers found statistically significant higher iAs concentrations, in hair and in blood, for children diagnosed with ASD compared with controls across studies. However, the findings on Pb exposure were inconsistent, with a significant association for hair Pb, no association for urinary Pb, and an inverse association for blood Pb. After considering strengths and limitations of the body of research, the authors concluded that there is consistent evidence supporting a positive association between early life iAs exposure and diagnosis of ASD and inconsistent evidence for Pb exposure and ASD risk. They believed it is in the best interest of policy makers and the public to reduce exposures to iAs and Pb among pregnant women and children. These investigators stated that their research supported the need for large, perspective human studies with accurate measurement and determination of the long-term body burden of iAs and Pb exposures to examine the impact of iAs and Pb exposures on ASD risk.
Aetna considers blood lead testing (measurement of blood lead level) medically necessary for diagnosis of persons with signs and symptoms of lead poisoning (e.g., lowered IQ scores, decreased attention span, impaired hearing, speech and other developmental delays, abdominal pain, headaches, vomiting, and constipation).